Role of Hepcidin on Response of Erythropoietin Stimulating Agents in Anaemic Advanced Chronic Kidney Disease Patients

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 10

Abstract

ABSTRACT Introduction: Anaemia contributes significantly to the morbidity and mortality in Chronic Kidney Diseases (CKD). Erythropoietin Stimulating Agents (ESA) have revolutionised the management of the anaemia in CKD patients. However, over 50% of the patients do not reach the target haemoglobin level. Hepcidin which plays important role in iron metabolism and inflammation may be the cause of this hyporesponsiveness to ESA. Aim: The present study was aimed to assess possible relation between hepcidin and erythropoietin therapy with special attention to hyporesponsive anaemia in advanced kidney disease. Materials and Methods: In this cross sectional study, total of 81 clinically stable patients from Department of Medicine and Nephrology, King George’s Medical University, Lucknow of advanced CKD on ESA for past 12 weeks were enrolled. Patients whose haemoglobin rose more than 2 gm/dL or were above 10 gm/dL were classified as responders while below 10 gm/dL were classified as poor responders. Results: In present study, majority 54 patients (66.7%) were poor responders to ESA. We found significant higher level of hepcidin in poor responders (p=0.01) while no significant variation in serum iron, Transferrin Saturation (TSAT) and ferritin. High sensitivity C-Reactive Protein (hsCRP) was markedly elevated with median value 3.13 mg/L and Interquartile Range (IQR) (1.14-13.78) in all patients. Conclusion: Hepcidin may be one of the causes of hyporesponsiveness to ESA due to reticulo-endothelial blockade of iron.

Authors and Affiliations

Satyendra Kumar Sonkar, Anil Kumar, Neeraj Kumar Singh, Gyanendra Kumar Sonkar, Sant Pandey, Vivek Bhosale

Keywords

Related Articles

Intraoperative Hyperkalemia Leading to Ventricular Tachycardia during Laparoscopic Renal Transplant

ABSTRACT Chronic kidney disease, consequent upon a variety of causes is a leading cause of morbidity and mortality. Renal transplantation is the preferred therapeutic approach for these patients. Hyperkalemia is a common...

The Potential Role of Social Media in Pharmacovigilance in Nepal: Glimpse from a Resource-limited Setting

ABSTRACT Introduction: An ever-increasing trend in the use of social media offers a potential forum for exchanging information in developing countries. Easy access, quick dissemination and widespread use necessitate the...

A Review of Measures against Increasing Temperature and Climate Change for the Safeguard of Workers in India

Severe heat causes various health related problems among the workers in India. Working under hot and humid environment damages health of workers especially the agriculture labourers, construction workers, rickshaw puller...

Bilateral Psammomatoid Ossifying Fibroma of Maxilla

ABSTRACT Ossifying-Fibroma (OF) is a benign neoplasm histopathologically composed of fibrocellularstroma and variable amount of mineralized material. Generally, these tumours in jaw bones are found as solitary lesions. O...

Download PDF file
  • EP ID EP526692
  • DOI 10.7860/JCDR/2018/36051.12142
  • Views 79
  • Downloads 0

How To Cite

Satyendra Kumar Sonkar, Anil Kumar, Neeraj Kumar Singh, Gyanendra Kumar Sonkar, Sant Pandey, Vivek Bhosale (2018). Role of Hepcidin on Response of Erythropoietin Stimulating Agents in Anaemic Advanced Chronic Kidney Disease Patients. Journal of Clinical and Diagnostic Research, 12(10), 14-16. https://europub.co.uk./articles/-A-526692